In order to fill this critical gap in technology, we developed and characterized a mouse model of asthma, influenza, and pneumococcal pneumonia (‘triple-disease’) through the combination of our fungal asthma model27 with a well-employed model of IAV and Spn co-infection28 thereby enabling the investigation of host-pathogen interactions in the in vivo setting. This evidence concerns the gene SPN and asthma.